Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
+$550M |
| 2 |
Procter & Gamble
PG
|
+$465M |
| 3 |
Microsoft
MSFT
|
+$425M |
| 4 |
L3Harris
LHX
|
+$402M |
| 5 |
Global Payments
GPN
|
+$355M |
Top Sells
| 1 |
RHT
Red Hat Inc
RHT
|
+$576M |
| 2 |
APC
Anadarko Petroleum
APC
|
+$457M |
| 3 |
WP
Worldpay, Inc.
WP
|
+$318M |
| 4 |
TSS
Total System Services, Inc.
TSS
|
+$296M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$280M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.28% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Criteo
CRTO
$1.15B
| $2.17M | ﹤0.01% |
116,331
+7,281
| +7% | +$136K |
|
|
CBIO
2852
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $2.17M | ﹤0.01% |
5,043
+370
| +8% | +$159K |
|
2853
Richmond Mutual Bancorp
RMBI
$141M
| $2.17M | ﹤0.01% |
+155,229
| New | +$2.17M |
|
2854
LoveSac
LOVE
$257M
| $2.16M | ﹤0.01% |
115,914
+11,426
| +11% | +$213K |
|
2855
Shore Bancshares
SHBI
$575M
| $2.16M | ﹤0.01% |
140,364
+155
| +0.1% | +$2.39K |
|
2856
Novo Nordisk
NVO
$241B
| $2.16M | ﹤0.01% |
83,426
+3,536
| +4% | +$91.4K |
|
2857
Evolution Petroleum
EPM
$180M
| $2.15M | ﹤0.01% |
368,682
+13,069
| +4% | +$76.3K |
|
2858
BGSF Inc
BGSF
$71.4M
| $2.14M | ﹤0.01% |
112,215
+2,451
| +2% | +$46.8K |
|
2859
Syndax Pharmaceuticals
SNDX
$1.41B
| $2.14M | ﹤0.01% |
286,238
+17,681
| +7% | +$132K |
|
|
IDE
2860
Voya Infrastructure, Industrials and Materials Fund
IDE
$189M
| $2.12M | ﹤0.01% |
185,505
+25,162
| +16% | +$288K |
|
2861
Verrica Pharmaceuticals
VRCA
$46.7M
| $2.12M | ﹤0.01% |
14,373
+6,181
| +75% | +$912K |
|
|
OPTN
2862
DELISTED
OptiNose
OPTN
| $2.12M | ﹤0.01% |
20,184
+712
| +4% | +$74.7K |
|
|
SWZ
2863
Swiss Helvetia Fund
SWZ
$79.5M
| $2.12M | ﹤0.01% |
263,946
| – | – |
|
|
TREC
2864
DELISTED
Trecora Resources
TREC
| $2.12M | ﹤0.01% |
234,865
+19,487
| +9% | +$176K |
|
|
PVLA
2865
Palvella Therapeutics, Inc. Common Stock
PVLA
$646M
| $2.12M | ﹤0.01% |
7,761
+4,428
| +133% | +$1.21M |
|
|
ATHX
2866
DELISTED
Athersys, Inc. Common Stock
ATHX
| $2.12M | ﹤0.01% |
63,626
+68
| +0.1% | +$2.26K |
|
2867
Norwood Financial Corp
NWFL
$248M
| $2.11M | ﹤0.01% |
66,865
+477
| +0.7% | +$15.1K |
|
2868
Globalstar
GSAT
$3.84B
| $2.11M | ﹤0.01% |
339,529
-25,295
| -7% | -$157K |
|
|
MSON
2869
DELISTED
Misonix Inc
MSON
| $2.1M | ﹤0.01% |
104,369
+2,028
| +2% | +$40.7K |
|
2870
Schwab International Equity ETF
SCHF
$51.5B
| – | – |
0
| – | -$2.1M |
|
2871
Scholar Rock
SRRK
$3.06B
| $2.09M | ﹤0.01% |
233,229
+16,276
| +8% | +$146K |
|
2872
Provident Bancorp
PVBC
$228M
| $2.08M | ﹤0.01% |
175,241
+198
| +0.1% | +$2.35K |
|
2873
Oil-Dri
ODC
$970M
| $2.08M | ﹤0.01% |
122,224
+16,284
| +15% | +$277K |
|
|
ZYNE
2874
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $2.08M | ﹤0.01% |
274,750
+16,641
| +6% | +$126K |
|
|
AVDR
2875
DELISTED
Avedro, Inc Common Stock
AVDR
| $2.07M | ﹤0.01% |
91,365
+13,289
| +17% | +$302K |
|